These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 8932991)
1. Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinaemic state. Ziv E; Kalman R; Hershkop K; Barash V; Shafrir E; Bar-On H Diabetologia; 1996 Nov; 39(11):1269-75. PubMed ID: 8932991 [TBL] [Abstract][Full Text] [Related]
2. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus. Shafrir E; Ziv E; Saha AK; Ruderman NB Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940 [TBL] [Abstract][Full Text] [Related]
3. Changing pattern of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally induced type 2 diabetes. Ziv E; Shafrir E; Kalman R; Galer S; Bar-On H Metabolism; 1999 Dec; 48(12):1549-54. PubMed ID: 10599987 [TBL] [Abstract][Full Text] [Related]
4. Psammomys obesus and the albino rat--two different models of nutritional insulin resistance, representing two different types of human populations. Kalman R; Ziv E; Shafrir E; Bar-On H; Perez R Lab Anim; 2001 Oct; 35(4):346-52. PubMed ID: 11669319 [TBL] [Abstract][Full Text] [Related]
5. Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil. Shafrir E; Spielman S; Nachliel I; Khamaisi M; Bar-On H; Ziv E Diabetes Metab Res Rev; 2001; 17(1):55-66. PubMed ID: 11241892 [TBL] [Abstract][Full Text] [Related]
6. Prevention of nutritionally induced diabetes by rosiglitazone in the gerbil Psammomys obesus. Hefetz S; Ziv E; Jörns A; Lenzen S; Shafrir E Diabetes Metab Res Rev; 2006; 22(2):139-45. PubMed ID: 16088969 [TBL] [Abstract][Full Text] [Related]
7. Low rate of glucose 6-phosphate hydrolysis in liver cells is a physiological feature of non-diabetic wild sand rats (Psammomys obesus). Koceir EA; Dahmani Y; Leverve X Diabetes Metab; 2003 Sep; 29(4 Pt 1):363-74. PubMed ID: 14526264 [TBL] [Abstract][Full Text] [Related]
8. Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to beta-cell apoptosis. Bar-On H; Ben-Sasson R; Ziv E; Arar N; Shafrir E Pancreas; 1999 Apr; 18(3):259-65. PubMed ID: 10206484 [TBL] [Abstract][Full Text] [Related]
9. Basal glucose turnover in Psammomys obesus. An animal model of type 2 (non-insulin-dependent) diabetes mellitus. Habito RC; Barnett M; Yamamoto A; Cameron-Smith D; O'Dea K; Zimmet P; Collier GR Acta Diabetol; 1995 Oct; 32(3):187-92. PubMed ID: 8590789 [TBL] [Abstract][Full Text] [Related]
10. Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). Shafrir E; Ziv E; Kalman R ILAR J; 2006; 47(3):212-24. PubMed ID: 16804196 [TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment. Leckström A; Ziv E; Shafrir E; Westermark P Pancreas; 1997 Nov; 15(4):358-66. PubMed ID: 9361089 [TBL] [Abstract][Full Text] [Related]
12. Non-insulin dependent diabetes mellitus in Psammomys obesus is independent of changes in tissue fatty acid composition. Collier GR; Collier FM; Sanigorski A; Walder K; Cameron-Smith D; Sinclair AJ Lipids; 1997 Mar; 32(3):317-22. PubMed ID: 9076669 [TBL] [Abstract][Full Text] [Related]
13. Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat). Jörns A; Tiedge M; Ziv E; Shafrir E; Lenzen S Virchows Arch; 2002 Jan; 440(1):63-9. PubMed ID: 11942578 [TBL] [Abstract][Full Text] [Related]
14. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia. Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171 [TBL] [Abstract][Full Text] [Related]
15. A cross-sectional and short-term longitudinal characterisation of NIDDM in Psammomys obesus. Barnett M; Collier GR; Collier FM; Zimmet P; O'Dea K Diabetologia; 1994 Jul; 37(7):671-6. PubMed ID: 7958537 [TBL] [Abstract][Full Text] [Related]
16. Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia. Zoltowska M; Ziv E; Delvin E; Stan S; Bar-On H; Kalman R; Levy E Atherosclerosis; 2001 Jul; 157(1):85-96. PubMed ID: 11427207 [TBL] [Abstract][Full Text] [Related]
17. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes. Leibowitz G; Yuli M; Donath MY; Nesher R; Melloul D; Cerasi E; Gross DJ; Kaiser N Diabetes; 2001 Feb; 50 Suppl 1():S113-7. PubMed ID: 11272167 [TBL] [Abstract][Full Text] [Related]
18. Leptin resistance in a polygenic, hyperleptinemic animal model of obesity and NIDDM: Psammomys obesus. Walder K; Lewandowski P; Morton G; Sanigorski A; de Silva A; Zimmet P; Collier GR Int J Obes Relat Metab Disord; 1999 Jan; 23(1):83-9. PubMed ID: 10094582 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes. Bouderba S; Sanchez-Martin C; Villanueva GR; Detaille D; Koceïr EA J Diabetes; 2014 Mar; 6(2):184-92. PubMed ID: 23953934 [TBL] [Abstract][Full Text] [Related]
20. Cellular mechanism of nutritionally induced insulin resistance: the desert rodent Psammomys obesus and other animals in which insulin resistance leads to detrimental outcome. Shafrir E; Ziv E J Basic Clin Physiol Pharmacol; 1998; 9(2-4):347-85. PubMed ID: 10212843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]